CZ2003306A3 - Transdermální náplast - Google Patents

Transdermální náplast Download PDF

Info

Publication number
CZ2003306A3
CZ2003306A3 CZ2003306A CZ2003306A CZ2003306A3 CZ 2003306 A3 CZ2003306 A3 CZ 2003306A3 CZ 2003306 A CZ2003306 A CZ 2003306A CZ 2003306 A CZ2003306 A CZ 2003306A CZ 2003306 A3 CZ2003306 A3 CZ 2003306A3
Authority
CZ
Czechia
Prior art keywords
nicotine
time
transdermal patch
tobacco
predetermined period
Prior art date
Application number
CZ2003306A
Other languages
Czech (cs)
English (en)
Inventor
Steven L. Burton
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of CZ2003306A3 publication Critical patent/CZ2003306A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CZ2003306A 2000-08-02 2001-08-02 Transdermální náplast CZ2003306A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22268500P 2000-08-02 2000-08-02

Publications (1)

Publication Number Publication Date
CZ2003306A3 true CZ2003306A3 (cs) 2003-08-13

Family

ID=22833253

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ2003306A CZ2003306A3 (cs) 2000-08-02 2001-08-02 Transdermální náplast

Country Status (15)

Country Link
EP (1) EP1313472A4 (fr)
JP (1) JP2004505053A (fr)
KR (1) KR20030022348A (fr)
CN (1) CN1468101A (fr)
AR (1) AR030092A1 (fr)
AU (2) AU2001284704B2 (fr)
BR (1) BR0112837A (fr)
CA (1) CA2418107A1 (fr)
CZ (1) CZ2003306A3 (fr)
EA (1) EA004718B1 (fr)
HU (1) HUP0300680A3 (fr)
MX (1) MXPA03000994A (fr)
PL (1) PL365609A1 (fr)
WO (1) WO2002009709A1 (fr)
ZA (1) ZA200300820B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660754B1 (en) * 2000-02-15 2003-12-09 Smithkline Beecham Corporation Method for reducing or eliminating smoking
US8042550B2 (en) * 2006-11-02 2011-10-25 Vladimir Nikolaevich Urtsev Smoke-simulating pipe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055478A (en) * 1986-06-19 1991-10-08 Cooper Thomas M Method for stopping smoking

Also Published As

Publication number Publication date
EP1313472A4 (fr) 2006-07-26
MXPA03000994A (es) 2004-08-02
HUP0300680A2 (hu) 2003-08-28
PL365609A1 (en) 2005-01-10
CA2418107A1 (fr) 2002-02-07
AU8470401A (en) 2002-02-13
AU2001284704B2 (en) 2005-10-13
EA200300217A1 (ru) 2003-10-30
HUP0300680A3 (en) 2012-09-28
WO2002009709A8 (fr) 2003-08-07
AR030092A1 (es) 2003-08-13
BR0112837A (pt) 2003-06-24
JP2004505053A (ja) 2004-02-19
EP1313472A1 (fr) 2003-05-28
WO2002009709A1 (fr) 2002-02-07
EA004718B1 (ru) 2004-08-26
ZA200300820B (en) 2004-04-22
KR20030022348A (ko) 2003-03-15
CN1468101A (zh) 2004-01-14

Similar Documents

Publication Publication Date Title
Schneider et al. The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments
Malcolm et al. The use of nicotine chewing gum as an aid to stopping smoking
Russell Nicotine intake and its regulation
US5055478A (en) Method for stopping smoking
US6660754B1 (en) Method for reducing or eliminating smoking
US4800204A (en) Method of controlling tobacco use
Li Wan Po Transdermal nicotine in smoking cessation: A meta-analysis
Jarvik et al. Pharmacological adjuncts for the treatment of tobacco dependence
Ween et al. What doctors should consider before prescribing e‐liquids for e‐cigarettes
Lancaster et al. An update on therapeutics for tobacco dependence
CZ2003306A3 (cs) Transdermální náplast
US6630449B2 (en) Method for reducing the effect of nicotine addiction and dependancy
US20040024028A1 (en) Method for reducing or eliminating smoking
AU2001284704A1 (en) Method for reducing or eliminating smoking
Huber et al. Successful smoking cessation
Cooke Therapeutic advances in the treatment of cigarette addiction
AU622614B2 (en) Improvements in or relating to organic compounds
Bhattacharyya et al. Therapy for Cessation of Smoking
Ellingrod Smoking cessation: What to tell patients about over-the-counter treatments
Sullivan et al. State of the art reviews: smoking cessation: a review of treatment considerations
Kaul Smoking cessation
Sullivan et al. State of the Art Reviews: Smoking Cessation.
Frenk et al. Nicotine Replacement Therapies
Mendelsohn, CP* & Richmond The nicotine patch: guidelines for practical use
Krishnan Smoking Cessation: Initial Insights into a New Drug